Recent studies published in Pediatric Research and related journals demonstrate that cumulative caffeine exposure in premature infants correlates with neurodevelopmental outcomes. These findings could influence clinical protocols in neonatal intensive care units, wherein caffeine is commonly used to stimulate respiratory function. Understanding precise dosing and exposure timing may optimize neurodevelopment while minimizing potential risks in this vulnerable patient population.